| 1 | 72606-35-0 | BRN 1142786 | BRN 1142786 | C17H25N3O2
| | |
| 2 | 274901-16-5 | 维达列汀 | Vildagliptin | C17H25N3O2
| 原料;抗糖;中间体;糖尿病;蛋白酶;膦配体;原料药;标准品;科研试剂;医药原料 | |
| 3 | 1133208-42-0 | 维格列汀杂质 | Vildagliptin D7 | C17H25N3O2
| | |
| 4 | 1036959-27-9 | (2R)-Vildagliptin | (2R)-Vildagliptin | C17H25N3O2
| 杂质对照品;110-维格列汀;对照品-杂质对照品 | |
| 5 | 154923-16-7 | 拉夫替丁杂质 11 | Lafutidine Impurity 10 | C17H25N3O2
| | |
| 6 | 1789703-37-2 | 维格列汀杂质E | vildagliptin Impurity E | C17H25N3O2
| 标准品;杂质对照品 | 杂质对照品;杂质对照品;标准品 |
| 7 | 688020-80-6 | 4-(哌啶-4-基)哌嗪-1-羧酸苄基酯 | 1-CBZ-4-(PIPERIDIN-4-YL)-PIPERAZINE | C17H25N3O2
| | |
| 8 | 946759-92-8 | 4-(4-BROMO-2-METHYLPHENOXY)PIPERIDINE | 4-(4-BROMO-2-METHYLPHENOXY)PIPERIDINE | C17H25N3O2
| | |
| 9 | 439111-75-8 | N-(4-MORPHOLINOPHENYL)-2-PIPERIDINOACETAMIDE | N-(4-MORPHOLINOPHENYL)-2-PIPERIDINOACETAMIDE | C17H25N3O2
| | |
| 10 | 865660-50-0 | 1-(4-BENZYLPIPERAZINO)-2-MORPHOLINO-1-ETHANONE | 1-(4-BENZYLPIPERAZINO)-2-MORPHOLINO-1-ETHANONE | C17H25N3O2
| | |
| 11 | 5430-60-4 | N-(5,6-dimethoxyquinolin-8-yl)hexane-1,6-diamine | N-(5,6-dimethoxyquinolin-8-yl)hexane-1,6-diamine | C17H25N3O2
| | |
| 12 | 338954-97-5 | 5,6-DIMETHYL-4-NITRO-1-OCTYL-1H-1,3-BENZIMIDAZOLE | 5,6-DIMETHYL-4-NITRO-1-OCTYL-1H-1,3-BENZIMIDAZOLE | C17H25N3O2
| | |
| 13 | 940505-99-7 | 3-{[(cyclohexylamino)carbonyl]amino}-N-propylbenzamide | 3-{[(cyclohexylamino)carbonyl]amino}-N-propylbenzamide | C17H25N3O2
| | |
| 14 | | 2-(4'-N-BOC-AMINOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE | 2-(4'-N-BOC-AMINOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE | C17H25N3O2
| | |
| 15 | 333747-84-5 | 4-{4-[(4-methyl-1-piperazinyl)carbonyl]benzyl}morpholine | 4-{4-[(4-methyl-1-piperazinyl)carbonyl]benzyl}morpholine | C17H25N3O2
| | |
| 16 | 940476-70-0 | 3-{[(cyclohexylamino)carbonyl]amino}-N-isopropylbenzamide | 3-{[(cyclohexylamino)carbonyl]amino}-N-isopropylbenzamide | C17H25N3O2
| | |
| 17 | 338406-18-1 | ETHYL 3-AMINO-3-[4-(2,6-DIMETHYLPHENYL)PIPERAZINO]ACRYLATE | ETHYL 3-AMINO-3-[4-(2,6-DIMETHYLPHENYL)PIPERAZINO]ACRYLATE | C17H25N3O2
| | |
| 18 | 438220-49-6 | 2-(3-(3,5-二甲基异噁唑-4-基)金刚烷-1-基)乙酰肼 | 2-[3-(3,5-dimethylisoxazol-4-yl)-1-adamantyl]acetohydrazide | C17H25N3O2
| | |
| 19 | | 4-{[4-(2,3-dimethylphenyl)-1-piperazinyl]carbonyl}morpholine | 4-{[4-(2,3-dimethylphenyl)-1-piperazinyl]carbonyl}morpholine | C17H25N3O2
| | |
| 20 | 277298-90-5 | Methanone, [4-(2-methoxyphenyl)-1-piperazinyl]-3-piperidinyl- | Methanone, [4-(2-methoxyphenyl)-1-piperazinyl]-3-piperidinyl- | C17H25N3O2
| | |
| 21 | | 2-(4-ethoxyanilino)-N'-(2-ethylcyclopentylidene)acetohydrazide | 2-(4-ethoxyanilino)-N'-(2-ethylcyclopentylidene)acetohydrazide | C17H25N3O2
| | |
| 22 | 20684-26-8 | 6-hydroxy-8-[5-(propan-2-ylamino)pentylamino]-1H-quinolin-5-one | 6-hydroxy-8-[5-(propan-2-ylamino)pentylamino]-1H-quinolin-5-one | C17H25N3O2
| | |
| 23 | 1260897-95-7 | tert-butyl 5-aminospiro[indoline-3,4'-piperidine]-1'-carboxylate | tert-butyl 5-aminospiro[indoline-3,4'-piperidine]-1'-carboxylate | C17H25N3O2
| | |
| 24 | 148274-76-4 | N-(beta-hydroxy-gamma-(N-phenylpiperazinepropyl))-2-pyrrolidinone | N-(beta-hydroxy-gamma-(N-phenylpiperazinepropyl))-2-pyrrolidinone | C17H25N3O2
| | |
| 25 | 925169-00-2 | N-(4-{[(cyclohexylamino)carbonyl]amino}phenyl)-2-methylpropanamide | N-(4-{[(cyclohexylamino)carbonyl]amino}phenyl)-2-methylpropanamide | C17H25N3O2
| | |
| 26 | | N-(CYCLOPROPYL)-N'-(2-METHOXYPHENYL)-N-(1-METHYLPIPERIDIN-4-YL)UREA | N-(CYCLOPROPYL)-N'-(2-METHOXYPHENYL)-N-(1-METHYLPIPERIDIN-4-YL)UREA | C17H25N3O2
| | |
| 27 | | [3-(3,5-DIMETHYL-ISOXAZOL-4-YL)-ADAMANTAN-1-YL]-ACETIC ACID HYDRAZIDE | [3-(3,5-DIMETHYL-ISOXAZOL-4-YL)-ADAMANTAN-1-YL]-ACETIC ACID HYDRAZIDE | C17H25N3O2
| | |
| 28 | 318517-18-9 | N3-(TERT-BUTYL)-N2-ETHYL-3,4-DIHYDRO-2,3(1H)-ISOQUINOLINEDICARBOXAMIDE | N3-(TERT-BUTYL)-N2-ETHYL-3,4-DIHYDRO-2,3(1H)-ISOQUINOLINEDICARBOXAMIDE | C17H25N3O2
| | |
| 29 | | 3-[[Ethyl(benzyl)amino]methyl]-4-hydroxy-2-oxo-1,3-diazaspiro[4.4]nonane | 3-[[Ethyl(benzyl)amino]methyl]-4-hydroxy-2-oxo-1,3-diazaspiro[4.4]nonane | C17H25N3O2
| | |
| 30 | 2055841-36-4 | 1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6-heptyl-1-(1-methylethyl)- | 1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6-heptyl-1-(1-methylethyl)- | C17H25N3O2
| | |
| 31 | | [2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(1,4,5-TRIMETHYL-1H-IMIDAZOL-2-YLMETHYL)-AMINE | [2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-(1,4,5-TRIMETHYL-1H-IMIDAZOL-2-YLMETHYL)-AMINE | C17H25N3O2
| | |
| 32 | 1353957-69-3 | 3-[(2-AMino-ethyl)-cyclopropyl-aMino]-pyrrolidine-1-carboxylic acid benzyl ester | 3-[(2-AMino-ethyl)-cyclopropyl-aMino]-pyrrolidine-1-carboxylic acid benzyl ester | C17H25N3O2
| | |
| 33 | 1053657-71-8 | N'-[1-Cyclobutylamino-2-phenylethylidene]-hydrazinecarboxylic acid tert-butyl ester | N'-[1-Cyclobutylamino-2-phenylethylidene]-hydrazinecarboxylic acid tert-butyl ester | C17H25N3O2
| | |
| 34 | 1354000-87-5 | (R)-3-[(2-AMino-ethyl)-cyclopropyl-aMino]-pyrrolidine-1-carboxylic acid benzyl ester | (R)-3-[(2-AMino-ethyl)-cyclopropyl-aMino]-pyrrolidine-1-carboxylic acid benzyl ester | C17H25N3O2
| | |
| 35 | 175553-48-7 | (2S)-[1-[(2S)-2-AMINO-1-OXOBUTYL]-N-BUTYL]-2,3-DIHYDRO-1H-INDOLE-2-CARBOXAMIDE OXALATE | (2S)-[1-[(2S)-2-AMINO-1-OXOBUTYL]-N-BUTYL]-2,3-DIHYDRO-1H-INDOLE-2-CARBOXAMIDE OXALATE | C17H25N3O2
| | |
| 36 | | (2S)-N-[(1S)-1-Hydroxymethyl-2-(1H-indol-3-yl)ethyl]-3-methyl-2-(methylamino)butanamide | (2S)-N-[(1S)-1-Hydroxymethyl-2-(1H-indol-3-yl)ethyl]-3-methyl-2-(methylamino)butanamide | C17H25N3O2
| | |
| 37 | 102141-01-5 | | Butanamide, N-[(1S)-2-hydroxy-1-(1H-indol-3-ylmethyl)ethyl]-3-methyl-2-(methylamino)-, (2S)- | C17H25N3O2
| | |
| 38 | 105310-25-6 | Cyclopropanecarboxamide, 2-[[(2-aminoacetyl)amino]methyl]-N,N-diethyl-1-phenyl-, (1R,2S)-rel- | Cyclopropanecarboxamide, 2-[[(2-aminoacetyl)amino]methyl]-N,N-diethyl-1-phenyl-, (1R,2S)-rel- | C17H25N3O2
| | |
| 39 | 845866-71-9 | (1S,4S)-(+)-[4-(2,5-DIAZA-BICYCLO[2.2.1]HEPT-2-YLMETHYL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER 2CF3COOH | (1S,4S)-(+)-[4-(2,5-DIAZA-BICYCLO[2.2.1]HEPT-2-YLMETHYL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER 2CF3COOH | C17H25N3O2
| | |